In addition to glucocorticoids, several medications are known to increase hip fracture risk, including thyroid hormone excess, aromatase inhibitors for the treatment of breast cancer, and androgen deprivation for the treatment of prostate cancer [77–81]; (Evidence level Ia). Here, CYP19A1 is linked to prostate cancer.